Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Sell
50
TRNS Quote, Financials, Valuation and Earnings
Last price:
$106.31
Seasonality move
:
10.54%
Day range:
$104.84 - $108.03
52-week range:
$94.29 - $147.12
Dividend yield:
0%
P/E ratio:
52.74x
P/S ratio:
3.53x
P/B ratio:
3.63x
Volume:
38K
Avg. volume:
56K
1-year change:
-3.28%
Market cap:
$975.2M
Revenue:
$259.5M
EPS (TTM):
$2.01
Analysts' Opinion
-
Consensus RatingTranscat has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $123.20, Transcat has an estimated upside of 14.33% from its current price of $106.01.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $119.00 representing 100% downside risk from its current price of $106.01.
Fair Value
-
According to the consensus of 3 analysts, Transcat has 14.33% upside to fair value with a price target of $123.20 per share.
TRNS vs. S&P 500
-
Over the past 5 trading days, Transcat has underperformed the S&P 500 by -1.39% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Transcat does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Transcat has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Transcat reported revenues of $67.8M.
Earnings Growth
-
Transcat has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Transcat reported earnings per share of $0.35.
Enterprise value:
954.4M
EV / Invested capital:
3.51x
Price / LTM sales:
3.53x
EV / EBIT:
41.36x
EV / Revenue:
3.53x
PEG ratio (5yr expected):
0.68x
EV / Free cash flow:
56.36x
Price / Operating cash flow:
56.46x
Enterprise value / EBITDA:
24.44x
Gross Profit (TTM):
$88.8M
Return On Assets:
6.12%
Net Income Margin (TTM):
6.63%
Return On Equity:
8.06%
Return On Invested Capital:
7.59%
Operating Margin:
5.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $217.9M | $242.9M | $270.6M | $62.8M | $67.8M | |
| Gross Profit | $63.1M | $74.4M | $88.8M | $20.1M | $21.2M | |
| Operating Income | $14.1M | $15.3M | $22.3M | $1.6M | $3.7M | |
| EBITDA | $24.8M | $26.3M | $39.1M | $5M | $8.2M | |
| Diluted EPS | $1.32 | $1.13 | $2.01 | $0.06 | $0.35 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $45.4M | $53.8M | $62.6M | $65.2M | $95.2M | |
| Total Assets | $126.1M | $158.3M | $186.7M | $248.2M | $323.6M | |
| Current Liabilities | $20.6M | $21.6M | $24.9M | $28.1M | $26.5M | |
| Total Liabilities | $56M | $77.6M | $94.4M | $110M | $54.8M | |
| Total Equity | $70.1M | $80.7M | $92.3M | $138.3M | $268.8M | |
| Total Debt | $22.7M | $43.1M | $50.8M | $53.3M | $3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $15.4M | $27.7M | $32.4M | $8.4M | $6.8M | |
| Cash From Investing | -$24M | -$28M | -$31.3M | -$12.7M | -$3.9M | |
| Cash From Financing | $6.9M | $901K | $21.7M | $3.2M | -$1.4M | |
| Free Cash Flow | $4.2M | $17.6M | $16.9M | $5.8M | $2.9M | |
TRNS
Sector
Market Cap
$975.2M
$764.9M
Price % of 52-Week High
72.06%
78.73%
Dividend Yield
0%
0%
Shareholder Yield
-5.67%
2.31%
1-Year Price Total Return
-3.28%
-2.09%
Beta (5-Year)
0.702
0.898
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$106.67
200-day SMA
Sell
Level
$117.47
Bollinger Bands (100)
Sell
Level
105.73 - 124.79
Chaikin Money Flow
Buy
Level
7.7M
20-day SMA
Sell
Level
$106.35
Relative Strength Index (RSI14)
Sell
Level
47.61
ADX Line
Buy
Level
23.82
Williams %R
Neutral
Level
-58.0576
50-day SMA
Sell
Level
$108.60
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
8.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.2973)
Buy
CA Score
(Annual)
Level (1.1248)
Buy
Beneish M-Score
(Annual)
Level (-2.5477)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-2.0468)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
Stock Forecast FAQ
In the current month, TRNS has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TRNS average analyst price target in the past 3 months is $123.20.
-
Where Will Transcat Stock Be In 1 Year?
According to analysts, the consensus estimate is that Transcat share price will rise to $123.20 per share over the next 12 months.
-
What Do Analysts Say About Transcat?
Analysts are divided on their view about Transcat share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Transcat is a Sell and believe this share price will drop from its current level to $119.00.
-
What Is Transcat's Price Target?
The price target for Transcat over the next 1-year time period is forecast to be $123.20 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TRNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Transcat is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TRNS?
You can purchase shares of Transcat via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Transcat shares.
-
What Is The Transcat Share Price Today?
Transcat was last trading at $106.31 per share. This represents the most recent stock quote for Transcat. Yesterday, Transcat closed at $106.01 per share.
-
How To Buy Transcat Stock Online?
In order to purchase Transcat stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
